The European Union (EU) has said that it will make pharmaceutical companies respect contracts they have signed for the supply of Covid-19 vaccines.
The statement by the EU follows a series of delays and slowdowns in the supply of the vaccines from some drugmakers.
According to a report from Reuters, this disclosure was made by the European Council President, Charles Michel, while speaking to Europe 1 radio on Sunday, January 24, 2021.
Michel in his statement said, “We plan to make the pharmaceutical companies respect the contracts they have signed … by using the legal means at our disposal.’’
While he made no mention of possible sanctions, Michel said that the EU would insist on transparency about the reasons for the delays.
He pointed out that after Pfizer’s first warnings about delays of several weeks, the EU had managed to reduce these delays by taking a tough stance.
Michel also said, “We banged our fist on the table and finally announced delays of several weeks turned into a slowdown of deliveries.’’
What you should know
- It can be recalled that Pfizer Inc last week announced that it was temporarily slowing supplies to Europe to make manufacturing changes that would boost output.
- On Friday, AstraZeneca also said that initial deliveries to the region will fall short because of a production glitch.
- Pfizer had been set to deliver about 80 million doses of the Covid-19 to the 27 countries by March.